Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Translating real-world evidence/real-world data.
Ravenstijn P. Ravenstijn P. Clin Transl Sci. 2024 May;17(5):e13835. doi: 10.1111/cts.13835. Clin Transl Sci. 2024. PMID: 38752299 Free PMC article. No abstract available.
Advancing the utilization of real-world data and real-world evidence in clinical pharmacology and translational research-Proceedings from the ASCPT 2023 preconference workshop.
Liu J, Rowland-Yeo K, Winterstein A, Dagenais S, Liu Q, Barrett JS, Zhu R, Ghobadi C, Datta-Mannan A, Hsu J, Menon S, Ahmed M, Manchandani P, Ravenstijn P. Liu J, et al. Among authors: ravenstijn p. Clin Transl Sci. 2024 Apr;17(4):e13785. doi: 10.1111/cts.13785. Clin Transl Sci. 2024. PMID: 38572980 Free PMC article. Review.
Therapeutic Innovations in Neuroscience: What's New on the Horizon?
Minichmayr IK, Ravenstijn P, van der Graaf PH, Vamvakas S. Minichmayr IK, et al. Among authors: ravenstijn p. Clin Pharmacol Ther. 2022 Apr;111(4):715-717. doi: 10.1002/cpt.2547. Clin Pharmacol Ther. 2022. PMID: 35313013 No abstract available.
Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial.
Recourt K, van der Aart J, Jacobs G, de Kam M, Drevets W, van Nueten L, Kanhai K, Siebenga P, Zuiker R, Ravenstijn P, Timmers M, van Gerven J, de Boer P. Recourt K, et al. Among authors: ravenstijn p. J Psychopharmacol. 2020 Sep;34(9):1030-1042. doi: 10.1177/0269881120914206. Epub 2020 Apr 4. J Psychopharmacol. 2020. PMID: 32248747 Clinical Trial.
24 results